A postdoctoral opportunity is immediately available at the Epigenetics Group, Lyon, France2.12.2016
A postdoctoral opportunity is immediately available within the Group to apply state-of-the-art molecular/cell biology and new functional genomic tools for mechanistic studies focusing on functionally important epigenetic “driver” genes (“epidrivers”) and associated molecular pathways. This also includes the development and application of in- vitro models (for example, human and mouse immortalization models), new (epi)genome editing tools, and functional genomics. We also study interactions of epidrivers with selected known and suspected carcinogens (with focus on non-genotoxic “epigenetic” agents) that may play a role in tumour initiation and progression through epigenetic mechanisms.
Candidates with a solid background in epigenetics, molecular biology, and cancer research with a good command of English are encouraged to apply. Experience in genome editing (such as CRISPR-Cas9 system), genome-wide shRNA screens and functional (epi)genomics would be an asset.
The postdoctoral opportunity is initially for one year with possibility of extension. The IARC stipend is currently €2750 per month (net of tax). The cost of travel for the post-doc, and in certain circumstances for dependants, will be met, a dependant’s allowance paid, and health insurance covered.
Applicants should send a CV, including list of publications and a description of previous research experience, as well as the names and addresses of two academic referees, preferably by email to: Email: email@example.com
To the attention of:
Dr Z. Herceg, Epigenetics Group
International Agency for Research on Cancer
150, cours Albert Thomas
69372 Lyon Cedex 08, France